Jesse McCann, MD
Retina Specialist · Tampa, FLNPI 1124319066
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 66.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $4,692 and has fallen 92.2% since, to $368 in 2025.
Across 66 payments — averaging $99.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Regeneron Healthcare Solutions, Inc.$784
- Genentech USA, Inc.$364
- Novartis$239
- Coherus Oncology, Inc.$171
- Apellis Pharmaceuticals, Inc.$154
- plus $514 from 12 others
What the payments were for
- Consulting fees$2,62540%
- Travel & lodging$1,35321%
- Food & beverage$2,48338%
- Education$941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $4,328 |
| Regeneron Healthcare Solutions, Inc. | 17 | $784 |
| Genentech USA, Inc. | 8 | $364 |
| Novartis | 5 | $239 |
| Coherus Oncology, Inc. | 2 | $171 |
| Apellis Pharmaceuticals, Inc. | 2 | $154 |
| Astellas Pharma US Inc | 6 | $131 |
| Mallinckrodt Hospital Products Inc. | 4 | $105 |
| Halozyme Inc | 1 | $61 |
| Alimera Sciences, Inc. | 2 | $45 |
| Dompe US, Inc. | 1 | $30 |
| Amgen(2 entities) | 2 | $29 |
| Biotissue Holdings Inc. | 1 | $23 |
| Sandoz | 1 | $22 |
| Johnson & Johnson Vision Care, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Eyepoint US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,555 in reported general payments places this provider in the 60th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 64 | $3,273 |
| Loteprednol Etabonate | 12 | $1,234 |
| Difluprednate | 11 | $1,176 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 113 | $1,143 |
| Brimonidine Tartrate | 56 | $698 |
| Latanoprost | 49 | $494 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $487 |
| Dorzolamide Hcl | 19 | $264 |
| ErythromycinErythromycin Base | 22 | $263 |
| Ketorolac Tromethamine | 15 | $240 |
| Timolol Maleate | 24 | $189 |
| Prednisone | 12 | $183 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Tampa
- Karina FindlayTampa$33K
- Mamta PatelTampa$6K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
- Timothy MurraySouth Miami$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.